Latest filing published 10 Apr 2019 for N4 Pharma PLC, €3,473.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +33.3%Entry 4.35 · Close at T+365 5.80
- +73.9%Entry 8.25 · Close at T+365 14.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nigel Theobald: trading record in brief
All filings by Nigel Theobald on record concern N4 Pharma PLC. The record holds 2 filings, for trades running from 10 November 2017 to 10 April 2019.
No open-market sale appears; the market trades are 2 purchases worth €8,540. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2019: 1 purchase and no sales on the market.
The newest entry dates from 10 April 2019: an open-market purchase of €3,473, in N4 Pharma PLC. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nigel Theobald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 67,343 shares@ £0.0444100.0% of flowLondon Stock Exchange, XLONISIN GB00BYW8QM32FCA-NSM:LSE20190410115211_14036236_20200326185043788_16879-0Canonical exit: 9 Jul 2019 (T+90)
- 56,656 shares@ £0.079359.3% of flowLondon Stock Exchange, AIMISIN GB00BYW8QM32FCA-NSM:LSE20171110160442_13428215_20200330131534375_9370Canonical exit: 8 Feb 2018 (T+90)
2 of 2 declarations